CN Patent

CN104414994A — 兰索拉唑肠溶胶囊及其制备工艺

Assigned to Hubei Ouly Pharmaceutical Co Ltd · Expires 2015-03-18 · 11y expired

What this patent protects

本发明公开了一种兰索拉唑肠溶胶囊，由丸芯和空胶囊壳组成，其特征在于其丸芯由含药里芯、隔离层及肠衣层构成，含药里芯处方包括兰索拉唑、淀粉、蔗糖、碱式碳酸镁、十二烷基硫酸钠及10％聚维酮K30，隔离衣处方包括羟丙基甲基纤维素、丙二醇、70％乙醇，肠溶衣处方包括Eudragit(L30D-55)、聚乙二醇6000、水，并公开了其制备过程。

USPTO Abstract

本发明公开了一种兰索拉唑肠溶胶囊，由丸芯和空胶囊壳组成，其特征在于其丸芯由含药里芯、隔离层及肠衣层构成，含药里芯处方包括兰索拉唑、淀粉、蔗糖、碱式碳酸镁、十二烷基硫酸钠及10％聚维酮K30，隔离衣处方包括羟丙基甲基纤维素、丙二醇、70％乙醇，肠溶衣处方包括Eudragit(L30D-55)、聚乙二醇6000、水，并公开了其制备过程。

Drugs covered by this patent

Patent Metadata

Patent number
CN104414994A
Jurisdiction
CN
Classification
—
Expires
2015-03-18
Drug substance claim
No
Drug product claim
No
Assignee
Hubei Ouly Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.